While a number of transcription factors that are likely to play a role in cardiac differentiation have recently been described, the signals that lead to the expression of these factors remains poorly understood. Here we report that exposure of Xenopus embryos to continuous low levels of all-trans retinoic acid (RA), starting at the time of neural fold closure, blocks expression of myocardial differentiation markers. The development of the remainder of the embryo is relatively normal, suggesting that retinoic acid can act rather specifically on myocardial precursors.
INTRODUCTION
, providing further evidence that the cardiogenic program is initiated at this stage. Differentiation of the Xenopus heart be-A growing number of transcription factors that play a role gins much later, at the tailbud stage (stage 26/27), based in early cardiac development have been identified. These both on changes in morphology (Nieuwkoop and Faber, include homeobox-containing genes related to Drosophila 1994) and on the expression of cardiac-specific differentiatinman (Lints et al., 1993; Tonissen et al., 1994; Schultheiss tion products (Logan and Mohun, 1993; Drysdale et al., et al., 1995; Evans et al., 1995; Lee et al., 1996 Lee et al., ), members 1994 Chambers et al., 1994) . of the MADS box family (Edmondson et al., 1994) , members Sater and Jacobson (1990) have shown that, in Xenopus, of the GATA family (Kelley et al., 1993) , and members of the precardiac tissue has characteristics of an embryonic the bHLH family (Srivastava et al., 1995) . However, the field, meaning that the area of tissue first specified to besignaling processes that initiate the expression of these faccome heart is larger than the area that will differentiate tors remain unknown. In Xenopus, embryological studies into heart. The process of generating a smaller heart-formhave determined that the heart precursor cells are specified, ing region does not appear to be due to migration of cardiac gaining the ability to express cardiac markers when cultured precursors. Instead, a signal that inhibits the cardiogenic in a neutral environment, during gastrulation (Sater and program at the periphery of the heart field is likely to be Jacobson, 1989; Nascone and Mercola, 1995) . Expression of responsible (Sater and Jacobson, 1990) . The nature of this several transcription factors known to be important for signal remains unknown. This restriction of the field may heart development commences during gastrulation (Kelley be related to the levels of the tinman-related genes Nkx2. 5 and Nkx2.3 . If the expression of these genes is elevated, a larger number of cells express cardiac differentiation mark-fertilization envelopes. Digoxygenin-labeled antisense RNA probes vated levels of these tinman-related proteins in the heart for whole-mount in situ hybridization were synthesized according field act to resist the normal contraction of the heart field to Harland (1991) except that the probes were resuspended directly (Cleaver et al., 1996; Chen and Fishman, 1996) .
in hybridization buffer without alkaline hydrolysis. The in situ
We have identified a simple treatment using retinoids hybridization protocol of Harland (1991) was used with the followthat causes a reduction in the expression of Nkx2.5 and ing modifications. Tris-buffered saline (50 mM Tris, pH 7.4, 200 Nkx2.3 and blocks differentiation of the myocardium. The mM NaCl) was used throughout rather than phosphate-buffered retinoid family of molecules acts on a variety of biological saline. Embryos were treated with 5 mg/ml proteinase K for 15 min.
functions through interactions with specific receptors and
The 0.21 SSC washes were increased to 1 hr in length, the washes binding proteins (reviewed in Giguere, 1994) . Exposure to after the antibody incubation were increased in frequency, and the total wash time was lengthened to 7 hr. RNase treatment used 1 exogenous retinoids is teratogenic for a wide variety of ml/ml of an RNase cocktail (Ambion). When the staining intensity structures, and these structures appear to be most vulnerawas sufficient for viewing, the embryos were passaged through the ble during the period of specification (Shenefelt, 1972) . In following washes for 5 min each: 25% methanol, 50% methanol, response to RA treatment, changes in cell fate are often 75% methanol, 100% methanol, 75% methanol, 50% methanol, observed (Kessel and Gruss, 1991) . More specifically, a num-25% methanol. After the washes, the embryos were fixed overnight ber of studies have shown that heart development is sensiin Bouin's fixative to give a yellow counterstain (Harland, 1991). tive to exogenous retinoid treatment (Osmond et al., 1991;  Embryos were cleared and photographed in 2 benzyl benzoate:1 Stainier and Fishman, 1992; Yutzey et al., 1994; Drysdale benzyl alcohol. et al., 1994) . Recently, heart defects have been observed in mice lacking one or more specific retinoic acid receptors, indicating that some aspect of RA signaling is required for Sectioning normal heart development (Sucov et al., 1994; et al., 1994) , cardiac Troponin I may be mimicking a pathway that restricts the heart field (XTnIc) (Drysdale et al., 1994) , cardiac a-actin (Mohun et al., 1984) , during normal cardiogenesis. 
MATERIALS AND METHODS RESULTS

Embryo Manipulations
Xenopus laevis embryos were generated as in Drysdale and Elin- causes severe axis defects and general loss of anterior strucEmbryos were treated with various concentrations of all-trans tures (Durston et al., 1989; a-actin expression is detectable in the heart region of RAtreated embryos, but expression in the somites appears to be unaffected. In addition to these molecular markers, no beating tissue is detectable when RA-treated embryos are allowed to develop until the beating heart stage (after about stage 34). RA treatment of Xenopus embryos starting at the gastrula stage causes severe reduction or ablation of the heart and most other anterior structures, including anterior neural tissues, cement gland, hatching gland, and eyes (Durston et al., 1989; Drysdale and Elinson, 1991; Drysdale and Crawford, 1994; Drysdale et al., 1994) . In contrast, the later, low-dose treatment described above results in very few defects in superficial morphology. Minor defects, however, are observed in the ventral part of the retina, which does not differentiate normally, in the tail, which does not fully elongate, and in gut morphogenesis. A similar retinal defect has previously been reported in RA-treated zebrafish (Hyatt et al., 1996) . To test for defects that might not be visible at the superficial level, neural tissues were detected with probe for neural-specific b-tubulin (Richter et al., 1988) . As illustrated in Fig. 1C , neural structures in RA-treated embryos appear normal, with the exception of the trigeminal ganglion which is stunted compared to controls. Note, however, that forebrain structures are present, indicating that no significant reduction of anterior neural structures has occurred. As development proceeds, the appearance of the RA-treated embryos becomes more abnormal and they begin to show severe edema, most likely due to cardiac insufficiency.
Retinoic Acid Blocks the Expression of Myocardial
Myocardial Development Is Sensitive to Retinoic Acid until the Time of Differentiation
To determine the period during which myocardial differentiation is sensitive to retinoid treatment, embryos were incubated in RA, starting at progressively later times during development. As shown in Fig. 2A , initiation of treatment at any stage up until late neurula (stage 23) completely eliminates all detectable expression of myocardial markers. A significant reduction in the size of the myocardium is observed when treatment is initiated at stage 25 (Fig. 2B) . However, when RA treatment is initiated at stage 28, just after the onset of myocardial differentiation (Logan and Mohun, 1993; Drysdale et al., 1994; Cleaver et al., 1996; Hemmati-Brivanlou et al., 1990) , there is little or no detectable alteration in heart development ( Fig. 2C) .
In this study, all embryos were assayed at the same developmental stage (stage 34), regardless of the time at which RA-treatment commenced. It is possible therefore, that the extent of myocardial marker expression depends on the total time that the developing myocardium is exposed to RA, rather than to the developmental stage at which the treatment is initiated. To test this possibility, embryos were exposed to constant 1 mM RA, starting at stage 28, and allowed to develop for several days. These embryos developed hearts of normal size and morphology, indicating that the stage at which treatment is initiated, rather than the duration, determines the extent of myocardial loss (data not shown).
The Pattern of XNkx-2.5 Expression Is Altered by Retinoic Acid
The homeobox sequence Nkx2.5 (XNkx2.5 in Xenopus) is expressed in cardiac progenitors and the adjacent pharyngeal region in the early embryo (Lints et al., 1993; Tonissen et al., 1994; Schultheiss et al., 1995; Lee et al., 1996) . In the Xenopus embryo, XNkx2.5 expression commences during gastrulation (stage 11-12) (Tonissen et al., 1994) , the time that the heart is thought to be specified (Sater and Jacobson, 1989; Nascone and Mercola, 1995) . Gene ablation studies in mouse indicate that Nkx2.5 is essential for normal cardiac morphogenesis (Lyons et al., 1995) and over-expression experiments in the frog suggest that XNkx2.5 normally functions to maintain precardiac mesoderm in a state competent to respond to additional cardiac differentiation signals (Cleaver et al., 1996) . The peak of XNkx2.5 expression in the Xenopus embryo occurs at the tailbud stage (Tonissen et al., 1994; Evans et al., 1995) about 8 hr before the onset of cardiac differentiation. To determine whether XNkx2.5 expression is susceptible to RA, embryos were exposed to continuous RA starting at stage 20/21 and then assayed by in situ hybridization at various later stages of development. It is important to emphasize that stage 20 is well after the onset of XNkx2.5 expression. As shown in Fig. 3A , embryos assayed at stage 24, only about 5 hr after initiation of RA treatment, showed greatly reduced expression of XNkx2.5. This decrease in expression is most pronounced in the precardiac region. In stage 32 embryos, where the heart tube is forming, XNkx2.5 transcripts remain visible in the pharyngeal region, but are undetectable in myocardial cells (Figs. 3B and 3C ). As the RA treatment was initiated at the time XNkx2.5 expression is at its peak in the embryo, the rapid decline in XNkx-2.5 transcripts suggests that the mRNA has a rather short half-life and that RA treatment effectively blocks expression of the XNkx2. 
XNkx2
.3, has an expression pattern almost identical to XNkx2.5 in the Xenopus embryo (Evans et al., 1995; Cleaver et al., 1996) and has the same biological properties when over-expressed in the embryo (Cleaver et al., 1996) . In situ hybridization experiments indicate that the profile of XNkx2.3 expression is the same as XNkx2.5 in embryos treated with RA (data not shown).
Limited Cardiac Morphogenesis Occurs in the Absence of Myocardial-Specific Gene Expression
To determine the fate of the presumptive myocardial cells in RA-treated embryos, tissue sections were examined after the time of cardiac differentiation. Control and RA-treated embryos assayed for expression of the myocardial-specific marker, XTnIc, are shown in Figs. 4A and 4B , respectively. The control embryo shows a region of intense XTnIc staining, restricted to the myocardial layer. The myocardial tissue has delaminated from the epithelial layer of cells and clearly encloses a region of unstained endocardial tissue. In comparison, the presumptive myocardial layer in the RAtreated embryo shows the same delaminated appearance, but is completely devoid of XTnIc expression.
The presence of endocardial tissue in the hearts of RAtreated embryos was assayed using the endothelial marker sequence, X-msr (Devic et al., 1996) . X-msr encodes a G protein-coupled receptor that is related to, but distinct from, the angiotensin II receptor, and which is expressed in developing endothelial tissues including the endocardium (Devic et al., 1996) . Control and RA-treated embryos at stage 32 were assayed for X-msr sequences by whole-mount in situ hybridization are shown in Figs. 4C and 4D , respectively. The endocardial layer in the control embryo is visible as a thin tubular structure, continuous with the developing vascular system and the appearance in RA-treated embryos is similar, although the developing vasculature of the head appears somewhat disorganized. Figures 4E and 4F show histological sections through the heart region of control and RA-treated embryos, respectively, assayed for X-msr sequences. The presence of a distinct group of endocardial cells in both control and RA-treated embryos demonstrates that endocardial development is largely resistant to RA treatment that eliminates detectable expression of myocardial markers. Figure 4G shows the endocardium in sections through a stage 35 control embryo, after the heart tube has folded. The stained endocardial layer is separated from a thinwalled and extensively folded myocardial layer. By comparison, the endocardial layer in the RA-treated embryo (Fig.   FIG. 3 . Expression of the tinman-related homeodomain sequence, 4H) is located in close contact to a thick-walled and unXNkx-2.5 in RA-treated embryos. XNkx-2.5 sequences were detected by whole-mount in situ hybridization. (A) RA treatment was initiated at stage 20/21 and embryos were assayed at stage 24. Control embryo is on the left. Note the loss of Nkx-2.5 expression from the cardiac precursor region but not from the pharyngeal repharyngeal region (ph) are indicated. (C) RA-treated embryo assayed at stage 32. Note that XNkx-2.5 transcripts are detected in the gion. (B) Control embryo assayed at stage 32, after the onset of myocardial marker expression. The folding heart tube (ht) and the pharyngeal region (ph) but not in the region of the heart tube (ht).
folded layer of tissue. This tissue layer would normally have sion of myocardial differentiation markers has commenced, formed differentiated myocardium. In the normal heart, the RA has no discernible effect on the myocardium. Although endocardium is separated from the myocardium by a layer previous studies have shown that exposure of gastrula stage of extracellular matrix material (the cardiac jelly) (reviewed embryos to RA causes loss of the myocardium (Sive et al., in Borg et al., 1995) . The immediate juxtaposition of the 1990), these embryos suffered severe truncations of all endocardium and the myocardial layers in the RA-treated dorso-anterior structures (Durston et al., 1989) . Under these embryos suggests that the extracellular matrix has failed to conditions, loss of the heart is likely to be a secondary effect, form and that a differentiated myocardium may be necesresulting from loss of other dorso-anterior structures that sary for cardiac jelly formation.
are required to specify the myocardium. This possibility is supported by experiments which demonstrate that a heartinducing signal emanates from dorso-anterior structures at
Retinoic Acid Can Block Myocardial
the time of gastrulation (Sater and Jacobson, 1989; Nascone and Mercola, 1995; Antin et al., 1994) . Although embryos appear relatively normal after RA When embryos are treated with RA during neurula stages treatment, some axial defects are observed (Fig. 1) . This (Fig. 1) , it is unlikely that the loss of myocardium is a secraises the possibility that RA affects myocardial differentiaondary effect, resulting from the influence of RA on another tion by causing defects in other tissues that subsequently tissue. First, the paucity of general embryonic defects sugresult in a block to myocardial differentiation. To test this gests that most tissues are developing normally. Second, possibility, the cardiac progenitor region, as deduced by no additional signals or trophic factors are necessary for XNkx2.5 expression (Tonissen et al., 1994) , was explanted formation of a functional heart in Xenopus after gastrulaat stage 20/21 and cultured in the presence of 1 mM RA.
Differentiation in Explants of Cardiac Progenitors
tion (Sater and Jacobson, 1989; Nascone and Mercola, 1995) . Control explants normally give rise to a differentiated heart Third, explants of the presumptive myocardium taken at and immediately adjacent tissues (Fig. 5C ), but in the presneurula stages (20/21), and cultured in the presence of RA, ence of RA no cardiac troponin I expression is detected in fail to form a myocardium (Fig. 5 ). the explants (Fig. 5D ). Since these explants inevitably conOur results strongly suggest that exogenous RA blocks tain some other tissue in addition to heart, we cannot comexpression of myocardial differentiation markers in general, pletely exclude the possibility that RA is blocking myocarand not just the expression of a subset of myocardial genes. dial differentiation by altering another tissue; however, our This is most clearly demonstrated by expression of the carresults indicate that the majority of tissues in the embryo diac a-actin gene, which is completely absent in the cardiac are not involved (see Fig. 5B ).
region of the embryo, but remains at normal levels in the somites (Fig. 1) . In addition, late stage embryos fail to exhibit any detectable heart beat, indicating a failure to form DISCUSSION the contractile apparatus. On the other hand, expression of endocardial genes and formation of the simple heart tube Retinoic Acid Can Block Myocardial appears to proceed normally in the presence of RA. The
Differentiation in a Stage-Specific Manner
fusion of the two heart primordia has already been initiated at the time RA is added (Nieuwkoop and Faber, 1994) , and, We have demonstrated that exogenous RA can comat later stages, a morphologically normal tube is present at pletely block the differentiation of the myocardium when the position of the myocardium (Figs. 4G and 4H) . Overall, applied at a relatively late stage in the cardiogenic program.
these observations suggest that the primary defect lies in The window of RA sensitivity extends until the tailbud stage when myocardial differentiation occurs. Once expresthe differentiation of the myocardium and does not result 
FIG. 5.
RA treatment of heart region explants. Explants of the presumptive cardiac region were taken from normal embryos at stage 20/ 21 and cultured until stage 33/34, well after the time of cardiac differentiation. In all panels, differentiated myocardial tissue is detected by whole-mount in situ hybridization to XTnIc transcripts. The fate of the explanted region can be seen by comparing a normal embryo (A), to a similar embryo from which the presumptive cardiac region has been removed (B). Control explants differentiate to form cardiac tissue (C), while explants incubated in 1 mM RA exhibit no detectable cardiac troponin I expression (D).
from the elimination of presumptive myocardial cells. We normally act to block precocious differentiation of the myocardium (Kastner et al., 1995) , raising the possibility that are not aware of any other example where limited morphoexogenous RA may be acting on such a function. Blocking genesis occurs in the absence of overt differentiation.
retinoid signaling by dietary insufficiency of vitamin A or by addition of anti-RA antibodies also results in cardiac defects (Twal et al., 1995) . Although the mechanism re-
How Is Retinoic Acid Exerting Its Effect?
mains unknown, addition of excess RA often results in simIt is clear that retinoids play a role in normal heart develilar defects to those observed when RA signaling is disopment. Mice lacking function of specific retinoid receprupted (Means and Gudas, 1995) . While addition of exogetors, or combinations of these receptors, often have defects nous RA is known to influence heart development in other in cardiac development (Sucov et al., 1994; Kastner et al., species (Osmond et al., 1991; Stainier and Fishman, 1992; although in all cases myocardial differentiation mark- Yutzey et al., 1994) , the observed effects do not include loss ers are expressed. It should be noted that a possible explanaof myocardial gene expression. The increased sensitivity of the developing Xenopus myocardium may result from a tion of the RXRa knockout phenotype is that RXRa may greater effective dose of RA, because the embryos are imspond to a reduction in the XNkx2.5/XNkx2.3 expression domain and we have found that the level of both XNkx2.5 mersed in a solution of RA. This is consistent with the observation that neural defects resulting from RA exposure and XNkx2.3 transcripts decline rapidly after RA treatment. However, it is unlikely that RA is the normal meare also more pronounced in Xenopus (Durston et al., 1989) when compared to mammalian embryos (Morriss-Kay et al., diatior of heart field contraction. While targeted disruption of retinoic acid receptors has a marked effect on 1991; Conlon and Rossant, 1992) .
The RA signaling pathway is capable of regulating gene cardiac development, enlarged hearts are never observed (Sucov et al., 1994; Kastner et al., 1995) . An increase in expression (Giguerre, 1994) and it is possible that exogenous RA alters the expression of a gene required for myocardial heart size might be expected if retinoic acid is normally responsible for reduction in the heart field. It is plausible, differentiation. One potential target of RA regulation is the homeodomain gene Nkx2.5 (Lints et al., 1993; Komura and however, that understanding the mechanism by which RA has its striking effect on myocardial differentiation, Izumo, 1993; Tonissen et al., 1994) , which is expressed at high levels in the developing heart and which is required will provide clues to the normal processes underlying heart field contraction. for correct heart development (Lyons et al., 1995) . We have shown that RA treatment rapidly reduces levels of XNkx2.5 transcript in the presumptive cardiac region (Fig. 3) . When Nkx2.5 expression is eliminated in the mouse, a beating ACKNOWLEDGMENTS heart still forms and most cardiac-specific gene expression is maintained, but the resulting heart is poorly developed heart development in frog, zebrafish, and chicken (Evans et al., 1995; Lee et al., 1996; Buchberger et al., 1996) , raising the possibility that additional tinman-related sequences are
